Piper Sandler Companies

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of September 22, 2026, upon the recommendation of the Nominating and Governance Committee of the Board of Directors (the “Board”) of Piper Sandler Companies (the “Company”), the Board elected Wendy L. Schoppert to serve as a director of the Company for an initial term expiring at the Company’s 2027 annual meeting of shareholders. Following Ms. Schoppert’s election to the Board, the size of the Company’s Board increased by one, from 10 to 11 directors. Ms. Schoppert has been appointed to serve on the Audit Committee of the Board. Ms. Schoppert was executive vice president and chief financial officer of Sleep Number Corporation from 2011 to 2014; senior vice president and chief information officer from 2008 to 2011; and senior vice president and general manager, International and New Channel Development from 2005 to 2008. Ms. Schoppert is also currently a director of DaVita, Inc., and Fossil Group, Inc. In connection with her service on the Board, Ms. Schoppert will participate in the Company’s 2026 non-employee director compensation program, receiving a pro-rated $100,000 annual cash retainer, a $60,000 initial equity grant, and a pro-rated $150,000 annual equity grant for the remainder of the fiscal year ending December 31, 2026. There are no arrangements or understandings between Ms. Schoppert and any other persons pursuant to which Ms. Schoppert was selected as a director of the Company. Ms. Schoppert has not engaged in any related person transactions (as defined in Item 404(a) of Regulation S-K) with the Company.

Item 7.01. Regulation FD Disclosure. On September 22, 2026, the Company issued a press release announcing the event discussed in Item 5.02 above, the text of which is furnished as Exhibit 99 hereto. The information contained in this Item 7.01 and Exhibit 99 is being furnished, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18 of the Exchange Act. Furthermore, the information contained in this Item 7.01 and Exhibit 99 shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.